best medicare part d plans for 2026
Medicare Part D plans for 2026 emphasize affordability and coverage tailored to specific medications, with top providers like Wellcare and Humana leading due to low premiums and quality ratings.
Top Plans Overview
Wellcare stands out with the lowest average premiums at $8.16 and the highest CMS Star Rating of 3.50 among major providers, making it ideal for budget- conscious beneficiaries. Humana excels in availability, offering $0-premium plans in over half of U.S. states, plus low out-of-pocket costs on multiple drug tiers. Other strong options include UnitedHealthcare, Aetna, and HealthSpring (formerly Cigna), noted for generics and honorable mentions in cost-quality balance.
Key Selection Factors
The best plan depends on your prescriptions, location, and pharmacy—use Medicare.gov's Plan Finder tool during the Annual Enrollment Period (ended December 7, 2025) to compare personalized costs. Premiums, deductibles, copays, and the donut hole redesign in 2026 (with a $2,000 out-of-pocket cap) heavily influence choices. Always verify drug formulary coverage, as plans like Wellcare Value Script or Humana Value Rx prioritize common generics and hypertension/cholesterol meds.
Changes and Trends
Many Part D plans changed or terminated for 2026, prompting widespread reviews amid premium hikes and benefit adjustments. Trending discussions highlight using Medicare.gov for precise comparisons over generic ads, avoiding low- premium traps with high copays. Experts recommend listing all current meds accurately and checking preferred pharmacies for true savings.
Comparison Table
Provider| Avg. Premium| CMS Stars| $0 Premium States| Strengths
---|---|---|---|---
Wellcare| $8.16| 3.50| 17| Lowest cost, top quality 1
Humana| Varies| 3.00| 26+| Widespread $0 plans 1
HealthSpring| Mid-range| 2.50| 11| Generics focus 1
TL;DR Bottom: Wellcare and Humana top 2026 lists for value; compare via Medicare.gov for your drugs.
Information gathered from public forums or data available on the internet and portrayed here.